News

The new drug application (NDA) seeks approval of dasatinib to treat chronic myelogenous leukemia, as well as Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia, in adult patients with resistance

Besides the nasal spray, ciclesonide is the active substance of an inhaled corticosteroid that is already approved in 35 countries worldwide for the treatment of persistent asthma. In

This nine-center clinical trial involves 20 patients who received a single injection of one of two doses of AdPEDF. Study participants will be evaluated at three and twelve

Antisoma will choose up to three compounds from the EcoBiotics portfolio to evaluate during the next year. If these evaluations yield positive results, Antisoma will have rights to

Under the terms of the ten-year agreement, Cipla will be responsible for the manufacturing and supply of the drug using Akorn’s formulation, and Akorn will be responsible for

The filing allows Quigley Pharma, a wholly owned subsidiary of Quigley Corporation, to begin human clinical trials following a 30-day review period. If the FDA has no further

Baxter initiated the verification study to address the rising public concern over the spread of the H5N1 virus outside of Asia, the recent demonstration that the H5N1 virus

The NIH’s Chemical Genomics Center (NCGC) was created as part of an NIH initiative to discover novel compounds that can be used to investigate fundamental biological questions or

The Anti-Infective Drugs Advisory Committee (AIDAC) voted that there was substantial evidence of safety and efficacy of Cubicin (daptomycin for injection) in the treatment of S. aureus bacteremia